Mark Ogunsusi joined K&L Gates as a partner in its health care and Food and Drug Administration practice in Washington, the firm announced Wednesday.
Ogunsusi’s practice focuses on regulatory matters involving pharmacy law, pharmaceutical pricing, and innovative value-based reimbursement arrangements. He advises entities on health-care and drug pricing programs, including the Medicaid Drug Rebate Program, discounted pricing under the Nonprofit Institutions Act, the 340B drug discount program, the Medicaid drug rebate program, and Federal Supply Schedule pricing, the firm said.
He joins from Powers Pyles Sutter & Verville.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.